The hottest Biosciences Substack posts right now

And their main takeaways
Category
Top Science Topics
axialdaily 19 implied HN points 03 Apr 23
  1. Axial partners with early-stage life sciences companies to invest in their vision and help them grow.
  2. GreenLight Biosciences uses cell-free RNA manufacturing for human health and agriculture, bringing down costs and expanding applications.
  3. GreenLight is transitioning their manufacturing scale from dsRNA to mRNA for vaccines and gene therapies.
ASeq Newsletter 29 implied HN points 08 Dec 23
  1. A new nanopore sequencing company, Lunar Biosciences, is hiring for a CSO position.
  2. Despite limited public information, funding from Fapon suggests Lunar Biosciences is legitimate.
  3. Lunar Biosciences may be following a similar sequencing approach to companies like Qitan, possibly due to expired IP opportunities.
ASeq Newsletter 29 implied HN points 14 Sep 23
  1. PacBio's raw accuracy has only slightly improved over 4 generations of instruments.
  2. Fundamental issues, like polymerase kinetics, may be limiting the accuracy of PacBio sequencing.
  3. PacBio has prioritized longer read lengths over accuracy, using cyclic consensus sequencing for improved results.
Axial 7 implied HN points 03 Mar 24
  1. Human Immunology Biosciences (HI-Bio) is a clinical-stage biotech company focused on precision medicines for immune-mediated diseases, with the aim to target specific cellular drivers of disease with therapeutics.
  2. HI-Bio's assets include felzartamab and HIB210, targeting dysfunctional plasma cells and other immune system components to potentially provide more effective treatments for diseases like membranous nephropathy and IgA nephropathy.
  3. The company utilizes a platform that integrates human genetics, immunophenotyping, data sciences, and therapeutic engineering to advance its clinical pipeline in understanding and addressing immune-mediated diseases.
ASeq Newsletter 0 implied HN points 19 Nov 24
  1. Electronic Biosciences is a company that has been around for a long time, focusing on nanopore technology for detection methods. They're known for getting funding from DARPA since around 2008.
  2. The company is developing new ways to control motion using magnetism, which could be cool in tech applications.
  3. The information about their patents shows they are continuing to innovate and explore different possibilities in the bioscience field.
Get a weekly roundup of the best Substack posts, by hacker news affinity: